Raw data - Discovery of the First-in-Class GSK-3ß/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease

Published: 15-05-2020| Version 1 | DOI: 10.17632/x29mkccvj3.1
Contributor:
Mariarosaria COnte

Description

Research data

Files